Custom Antibody Development Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512248902

Publication Date:

December 9, 2024

Pages:

153

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Custom Antibody Development Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Custom Antibody Development Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Custom Antibody Development Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Custom Antibody Development Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Custom Antibody Development Service include R&D Systems, GenScript, Bio-Rad Laboratories, Bio-Techne, Abcam, Sino Biological, OriGene, Innovagen and AltaBioscience, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Custom Antibody Development Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Custom Antibody Development Service by region & country, by Type, and by Application.
The Custom Antibody Development Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Custom Antibody Development Service.
麻豆原创 Segmentation
By Company
R&D Systems
GenScript
Bio-Rad Laboratories
Bio-Techne
Abcam
Sino Biological
OriGene
Innovagen
AltaBioscience
Inotiv
Creative Biolabs
Rockland
Biosynth
ProSci
Abclonal
Eurogentec
Creative Diagnostics
BioGenes
BBI Solutions
BIOTEM
Boster Bio
2B Scientific
Merck
Antibody Production Services
ProteoGenix
BioServUK
Antibodies Inc
ProMab Biotechnologies
Diaclone
RayBiotech Life
Precision Antibody
ABEOMICS
Genosphere Biotechnologies
Protein Ark
Segment by Type:
Monoclonal Antibody Development Service
Polyclonal Antibody Development Service
Segment by Application
Pharmaceutical
Biotechnology
Academic Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Custom Antibody Development Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Custom Antibody Development Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Custom Antibody Development Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Custom Antibody Development Service Product Introduction
1.2 Global Custom Antibody Development Service 麻豆原创 Size Forecast
1.3 Custom Antibody Development Service 麻豆原创 Trends & Drivers
1.3.1 Custom Antibody Development Service Industry Trends
1.3.2 Custom Antibody Development Service 麻豆原创 Drivers & Opportunity
1.3.3 Custom Antibody Development Service 麻豆原创 Challenges
1.3.4 Custom Antibody Development Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Custom Antibody Development Service Players Revenue Ranking (2023)
2.2 Global Custom Antibody Development Service Revenue by Company (2019-2024)
2.3 Key Companies Custom Antibody Development Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Custom Antibody Development Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Custom Antibody Development Service
2.6 Custom Antibody Development Service 麻豆原创 Competitive Analysis
2.6.1 Custom Antibody Development Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Custom Antibody Development Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Antibody Development Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibody Development Service
3.1.2 Polyclonal Antibody Development Service
3.2 Global Custom Antibody Development Service Sales Value by Type
3.2.1 Global Custom Antibody Development Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Custom Antibody Development Service Sales Value, by Type (2019-2030)
3.2.3 Global Custom Antibody Development Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Biotechnology
4.1.3 Academic Research
4.1.4 Others
4.2 Global Custom Antibody Development Service Sales Value by Application
4.2.1 Global Custom Antibody Development Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Custom Antibody Development Service Sales Value, by Application (2019-2030)
4.2.3 Global Custom Antibody Development Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Custom Antibody Development Service Sales Value by Region
5.1.1 Global Custom Antibody Development Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Custom Antibody Development Service Sales Value by Region (2019-2024)
5.1.3 Global Custom Antibody Development Service Sales Value by Region (2025-2030)
5.1.4 Global Custom Antibody Development Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Custom Antibody Development Service Sales Value, 2019-2030
5.2.2 North America Custom Antibody Development Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Custom Antibody Development Service Sales Value, 2019-2030
5.3.2 Europe Custom Antibody Development Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Custom Antibody Development Service Sales Value, 2019-2030
5.4.2 Asia Pacific Custom Antibody Development Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Custom Antibody Development Service Sales Value, 2019-2030
5.5.2 South America Custom Antibody Development Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Custom Antibody Development Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Custom Antibody Development Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Custom Antibody Development Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Custom Antibody Development Service Sales Value
6.3 United States
6.3.1 United States Custom Antibody Development Service Sales Value, 2019-2030
6.3.2 United States Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Custom Antibody Development Service Sales Value, 2019-2030
6.4.2 Europe Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Custom Antibody Development Service Sales Value, 2019-2030
6.5.2 China Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Custom Antibody Development Service Sales Value, 2019-2030
6.6.2 Japan Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Custom Antibody Development Service Sales Value, 2019-2030
6.7.2 South Korea Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Custom Antibody Development Service Sales Value, 2019-2030
6.8.2 Southeast Asia Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Custom Antibody Development Service Sales Value, 2019-2030
6.9.2 India Custom Antibody Development Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Custom Antibody Development Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 R&D Systems
7.1.1 R&D Systems Profile
7.1.2 R&D Systems Main Business
7.1.3 R&D Systems Custom Antibody Development Service Products, Services and Solutions
7.1.4 R&D Systems Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.1.5 R&D Systems Recent Developments
7.2 GenScript
7.2.1 GenScript Profile
7.2.2 GenScript Main Business
7.2.3 GenScript Custom Antibody Development Service Products, Services and Solutions
7.2.4 GenScript Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.2.5 GenScript Recent Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Profile
7.3.2 Bio-Rad Laboratories Main Business
7.3.3 Bio-Rad Laboratories Custom Antibody Development Service Products, Services and Solutions
7.3.4 Bio-Rad Laboratories Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Techne Recent Developments
7.4 Bio-Techne
7.4.1 Bio-Techne Profile
7.4.2 Bio-Techne Main Business
7.4.3 Bio-Techne Custom Antibody Development Service Products, Services and Solutions
7.4.4 Bio-Techne Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Techne Recent Developments
7.5 Abcam
7.5.1 Abcam Profile
7.5.2 Abcam Main Business
7.5.3 Abcam Custom Antibody Development Service Products, Services and Solutions
7.5.4 Abcam Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.5.5 Abcam Recent Developments
7.6 Sino Biological
7.6.1 Sino Biological Profile
7.6.2 Sino Biological Main Business
7.6.3 Sino Biological Custom Antibody Development Service Products, Services and Solutions
7.6.4 Sino Biological Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.6.5 Sino Biological Recent Developments
7.7 OriGene
7.7.1 OriGene Profile
7.7.2 OriGene Main Business
7.7.3 OriGene Custom Antibody Development Service Products, Services and Solutions
7.7.4 OriGene Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.7.5 OriGene Recent Developments
7.8 Innovagen
7.8.1 Innovagen Profile
7.8.2 Innovagen Main Business
7.8.3 Innovagen Custom Antibody Development Service Products, Services and Solutions
7.8.4 Innovagen Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.8.5 Innovagen Recent Developments
7.9 AltaBioscience
7.9.1 AltaBioscience Profile
7.9.2 AltaBioscience Main Business
7.9.3 AltaBioscience Custom Antibody Development Service Products, Services and Solutions
7.9.4 AltaBioscience Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.9.5 AltaBioscience Recent Developments
7.10 Inotiv
7.10.1 Inotiv Profile
7.10.2 Inotiv Main Business
7.10.3 Inotiv Custom Antibody Development Service Products, Services and Solutions
7.10.4 Inotiv Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.10.5 Inotiv Recent Developments
7.11 Creative Biolabs
7.11.1 Creative Biolabs Profile
7.11.2 Creative Biolabs Main Business
7.11.3 Creative Biolabs Custom Antibody Development Service Products, Services and Solutions
7.11.4 Creative Biolabs Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.11.5 Creative Biolabs Recent Developments
7.12 Rockland
7.12.1 Rockland Profile
7.12.2 Rockland Main Business
7.12.3 Rockland Custom Antibody Development Service Products, Services and Solutions
7.12.4 Rockland Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.12.5 Rockland Recent Developments
7.13 Biosynth
7.13.1 Biosynth Profile
7.13.2 Biosynth Main Business
7.13.3 Biosynth Custom Antibody Development Service Products, Services and Solutions
7.13.4 Biosynth Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.13.5 Biosynth Recent Developments
7.14 ProSci
7.14.1 ProSci Profile
7.14.2 ProSci Main Business
7.14.3 ProSci Custom Antibody Development Service Products, Services and Solutions
7.14.4 ProSci Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.14.5 ProSci Recent Developments
7.15 Abclonal
7.15.1 Abclonal Profile
7.15.2 Abclonal Main Business
7.15.3 Abclonal Custom Antibody Development Service Products, Services and Solutions
7.15.4 Abclonal Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.15.5 Abclonal Recent Developments
7.16 Eurogentec
7.16.1 Eurogentec Profile
7.16.2 Eurogentec Main Business
7.16.3 Eurogentec Custom Antibody Development Service Products, Services and Solutions
7.16.4 Eurogentec Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.16.5 Eurogentec Recent Developments
7.17 Creative Diagnostics
7.17.1 Creative Diagnostics Profile
7.17.2 Creative Diagnostics Main Business
7.17.3 Creative Diagnostics Custom Antibody Development Service Products, Services and Solutions
7.17.4 Creative Diagnostics Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.17.5 Creative Diagnostics Recent Developments
7.18 BioGenes
7.18.1 BioGenes Profile
7.18.2 BioGenes Main Business
7.18.3 BioGenes Custom Antibody Development Service Products, Services and Solutions
7.18.4 BioGenes Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.18.5 BioGenes Recent Developments
7.19 BBI Solutions
7.19.1 BBI Solutions Profile
7.19.2 BBI Solutions Main Business
7.19.3 BBI Solutions Custom Antibody Development Service Products, Services and Solutions
7.19.4 BBI Solutions Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.19.5 BBI Solutions Recent Developments
7.20 BIOTEM
7.20.1 BIOTEM Profile
7.20.2 BIOTEM Main Business
7.20.3 BIOTEM Custom Antibody Development Service Products, Services and Solutions
7.20.4 BIOTEM Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.20.5 BIOTEM Recent Developments
7.21 Boster Bio
7.21.1 Boster Bio Profile
7.21.2 Boster Bio Main Business
7.21.3 Boster Bio Custom Antibody Development Service Products, Services and Solutions
7.21.4 Boster Bio Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.21.5 Boster Bio Recent Developments
7.22 2B Scientific
7.22.1 2B Scientific Profile
7.22.2 2B Scientific Main Business
7.22.3 2B Scientific Custom Antibody Development Service Products, Services and Solutions
7.22.4 2B Scientific Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.22.5 2B Scientific Recent Developments
7.23 Merck
7.23.1 Merck Profile
7.23.2 Merck Main Business
7.23.3 Merck Custom Antibody Development Service Products, Services and Solutions
7.23.4 Merck Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.23.5 Merck Recent Developments
7.24 Antibody Production Services
7.24.1 Antibody Production Services Profile
7.24.2 Antibody Production Services Main Business
7.24.3 Antibody Production Services Custom Antibody Development Service Products, Services and Solutions
7.24.4 Antibody Production Services Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.24.5 Antibody Production Services Recent Developments
7.25 ProteoGenix
7.25.1 ProteoGenix Profile
7.25.2 ProteoGenix Main Business
7.25.3 ProteoGenix Custom Antibody Development Service Products, Services and Solutions
7.25.4 ProteoGenix Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.25.5 ProteoGenix Recent Developments
7.26 BioServUK
7.26.1 BioServUK Profile
7.26.2 BioServUK Main Business
7.26.3 BioServUK Custom Antibody Development Service Products, Services and Solutions
7.26.4 BioServUK Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.26.5 BioServUK Recent Developments
7.27 Antibodies Inc
7.27.1 Antibodies Inc Profile
7.27.2 Antibodies Inc Main Business
7.27.3 Antibodies Inc Custom Antibody Development Service Products, Services and Solutions
7.27.4 Antibodies Inc Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.27.5 Antibodies Inc Recent Developments
7.28 ProMab Biotechnologies
7.28.1 ProMab Biotechnologies Profile
7.28.2 ProMab Biotechnologies Main Business
7.28.3 ProMab Biotechnologies Custom Antibody Development Service Products, Services and Solutions
7.28.4 ProMab Biotechnologies Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.28.5 ProMab Biotechnologies Recent Developments
7.29 Diaclone
7.29.1 Diaclone Profile
7.29.2 Diaclone Main Business
7.29.3 Diaclone Custom Antibody Development Service Products, Services and Solutions
7.29.4 Diaclone Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.29.5 Diaclone Recent Developments
7.30 RayBiotech Life
7.30.1 RayBiotech Life Profile
7.30.2 RayBiotech Life Main Business
7.30.3 RayBiotech Life Custom Antibody Development Service Products, Services and Solutions
7.30.4 RayBiotech Life Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.30.5 RayBiotech Life Recent Developments
7.31 Precision Antibody
7.31.1 Precision Antibody Profile
7.31.2 Precision Antibody Main Business
7.31.3 Precision Antibody Custom Antibody Development Service Products, Services and Solutions
7.31.4 Precision Antibody Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.31.5 Precision Antibody Recent Developments
7.32 ABEOMICS
7.32.1 ABEOMICS Profile
7.32.2 ABEOMICS Main Business
7.32.3 ABEOMICS Custom Antibody Development Service Products, Services and Solutions
7.32.4 ABEOMICS Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.32.5 ABEOMICS Recent Developments
7.33 Genosphere Biotechnologies
7.33.1 Genosphere Biotechnologies Profile
7.33.2 Genosphere Biotechnologies Main Business
7.33.3 Genosphere Biotechnologies Custom Antibody Development Service Products, Services and Solutions
7.33.4 Genosphere Biotechnologies Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.33.5 Genosphere Biotechnologies Recent Developments
7.34 Protein Ark
7.34.1 Protein Ark Profile
7.34.2 Protein Ark Main Business
7.34.3 Protein Ark Custom Antibody Development Service Products, Services and Solutions
7.34.4 Protein Ark Custom Antibody Development Service Revenue (US$ Million) & (2019-2024)
7.34.5 Protein Ark Recent Developments
8 Industry Chain Analysis
8.1 Custom Antibody Development Service Industrial Chain
8.2 Custom Antibody Development Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Custom Antibody Development Service Sales Model
8.5.2 Sales Channel
8.5.3 Custom Antibody Development Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

R&D Systems
GenScript
Bio-Rad Laboratories
Bio-Techne
Abcam
Sino Biological
OriGene
Innovagen
AltaBioscience
Inotiv
Creative Biolabs
Rockland
Biosynth
ProSci
Abclonal
Eurogentec
Creative Diagnostics
BioGenes
BBI Solutions
BIOTEM
Boster Bio
2B Scientific
Merck
Antibody Production Services
ProteoGenix
BioServUK
Antibodies Inc
ProMab Biotechnologies
Diaclone
RayBiotech Life
Precision Antibody
ABEOMICS
Genosphere Biotechnologies
Protein Ark

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.